Skip to main content
Clinical Trials/IRCT20090525001946N11
IRCT20090525001946N11
Recruiting
Phase 3

Investigating the effects of magnesium sulfate compared to placebo in controlling pain during the first 24 hours after cesarean delivery with spinal anesthesia in pregnant women, a double-blind study

Rasht University of Medical Sciences0 sites118 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
118
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Cesarean section with spinal anesthesia
  • Placement in class II of anesthesia
  • Being nuli para
  • Acceptable candidate for caesarean section

Exclusion Criteria

  • Magnesium intake 24 hours before surgery
  • History of any surgery
  • Suffering from kidney dysfunction
  • Suffering from heart dysfunction
  • Suffering from Lung dysfunction
  • Suffering from Liver dysfunction
  • Suffering from Myopathy dysfunction
  • Suffering from neuropathy dysfunction
  • Occurrence of severe preeclampsia symptoms
  • Occurrence of eclampsia symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials